ЭОЗИНОФИЛЬНЫЙ ГАСТРИТ У ДЕТЕЙ
Об авторах
Е. А. КорниенкоРоссия
Н. И. Паролова
Россия
Н. Л. Волкова
Россия
Е. В. Шилова
Россия
Г. В. Иванов
Россия
Л. В. Лопатина
Россия
Список литературы
1. Rothenberg M. E. Eosinophilic gastrointestinal disorders (EGID) // J Allergy Clin Immunol.- 2004.- Vol. 113.- P 11-28.
2. Fleischer D. M., Atkins D. Evaluation of the patient with suspected eosinophilic gastrointestinal disease // Immunol. Allergy Clin. North Am.- 2009.- Vol. 29.- P 53-63.
3. Jensen E. T, Martin C. F., Kappelman M. D., et al. Prevalence of eosinophilic gastritis, gastroenteritis and colitis: estimates from a national administrative database - J. Ped.Gastroenterol. Nutr., 2016, v62: p.36-42.
4. Klein N. C., Hargrove R. L., Sleisenger M. H., Jeffries G. H.Eo-sinophilic gastroenteritis // Medicine (Baltimore).-1970.- Vol. 49.- P 299-319.
5. Lucendo A. J., Arias A., De Rezende L. C., et al. Subepithelial collagen deposition, profibrogenic cytokine gene expression, and changes after prolonged fluticasone propionate treatment in adult eosinophilic esophagitis: a prospective study // J. Allergy Clin. Immunol.- 2011.- Vol. 128(5).- P 1037-1046.
6. Straumann A., Conus S., Degen L., et al. Budesinide is effective in adolescent and adult patients with active eosinophilic esophagitis // Gastroenterology- 2010.- Vol.139(5).-P 1526-1537.
7. Aceves S. S., Newbury R. O., Chen D., et al. Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids //Allergy- 2010.-Vol.65(1).- P. 109-116.
8. Straumann A., Conus S., Degen L., et al. Long-term budesonide maintenance treatment in partially effective for patients with eosinophilic esophagitis // Clin. Gastroenterol. Hepatol. - 2011.- Vol.9(5).- P 400-409.
9. Jawairia M., Shahzad G., Mustacchia P Eosinophilic gastrointestinal diseases: Review and update// ISRN Gastroenterol.-2012.-463689. выздоровлением, у 37% симптомы периодически обострялись и у 21% персистировали постоянно. Более высокий риск последующих обострений имеют те больные, у которых повышено количество эози-нофилов в крови [34]. Дети раннего возраста имеют высокие шансы полного выздоровления при условии строгого соблюдения элиминационной диеты.
10. Ziegler S. F. The role of thymic stromal lymphopoietin (TSLP) in allergic disorders // Curr.Opn. Immunol.- 2010.- Vol.22(6).-P. 795-799.
11. Collins M.H. Histopathology associated with eosinophilic gastrointestinal diseases. Immunol Allergy Clin North Am. - 2009.-vol.29 - P 109-117.
12. Torrente F, Barabino A, Bellini T, et al.Intraepithelial lymphocyte eotaxin-2 expression and perineural mast cell degranulation differentiate allergic/eosinophilic colitis from classic IBD. J Pediatr Gastroenterol Nutr.- 2014.- vol.59 - P. 300-307.
13. Kweon M.N, Yamamoto M, Kajiki M, et al. Systemically derived large intestinal CD4(d) Th2 cells play a central role in STAT6-mediated allergic diarrhea. J Clin Invest.- 2000 -vol.106 -P. 199-206.
14. Furuta G.T, Liacouras C.A, Collins M.H, et al. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology - 2007.- Vol.133 - P 1342-1363.
15. Foster B, Foroughi S, Yin Y et al. Effect of anti-IgE therapy on food allergen specific T cell responses in eosinophil associated gastrointestinal disorders. Clin Mol Allergy - 2011 - Vol.9.- P 7.
16. Mir SA, Schady D, Olive AP et al. Mucosal mast cell counts in pediatric eosinophilic gastrointestinal disease. Pediatr Allergy Immunol - 2014.- Vol.25.- P. 94-95.
17. Chehade M, Magid MS, Mofidi S, et al. Allergic eosinophilic gastroenteritis with protein-losing enteropathy: intestinal pathology, clinical course, and long-term follow-up. J Pediatr Gastroenterol Nutr - 2006 - Vol.42 - P. 516-521.
18. Shoda T, Nomura I., Matsuda A., et al. Gene expression profiles of mucosal biopsy specimens in children with eosinophilic gastritis. World Allergy Organization Journal.- 2015 - Vol.8 (Suppl 1) - A176.
19. Caldwell J. M., Collins M. H., Stucke E. M., et al. Histologic eosinophilic gastritis is a systemic disorder associated with blood and extragastric eosinophilia, TH2 immunity, and a unique gastric transcriptome. J Allergy Clin Immunol.- 2014 -Vol.134(5).- P 1114-1124.
20. Ko H. M., Morotti R.,Yershov O.,Chehade M. Eosinophilic gastritis in children: clinic-pathological correlation, disease course, and response to therapy. Am. J. Gastroenterol.-2014 - Vol.109 - P 1277-1285.
21. Lwin T, Melton S.D, Genta R.M. Eosinophilic gastritis: histo-pathological characterization and quantification of the normal gastric eosinophil content. Mod Pathol - 2011.- Vol.24 -P. 556-563.
22. Lucendo AJ, Serrano-Montalban B, Arias A, et al. Efficacy of dietary treatment for inducing disease remission in eosinophilic gastroenteritis. J Pediatr Gastroenterol Nutr - 2015ю -Vol.61 - P. 56-64.
23. Prussin C. Eosinophilic gastroenteritis and related eosinophilic disorders. Gastroenterol Clin North Am.- 2014.- Vol.43 -P. 317-327.
24. Naramore S.,Gupta S. K. NonesophagealEosinophilic Gastrointestinal Disorders: Clinical Care and Future Directions - J Pediatr Gastroenterol Nutr - 2018 - Vol.67 (S.3) -316-321.
25. Rosenfeldt V, et al. Effect of probiotic Lactobacillus strains in children with atopic dermatitis // J Allergy Clin Immunol.-2003.- Vol.111- P. 389-395.
26. Lucendo AJ, Serrano-Montalban B, Arias A, et al. Efficacy of dietary treatment for inducing disease remission in eosinophilic gastroenteritis. J Pediatr Gastroenterol Nutr - 2015ю -Vol.61 - P. 56-64.
27. Melamed I., Feanny S. J., Sherman P. M., Roifman C. M. Benefit of ketotifen in patients with eosinophilic gastroenteritis // Am.J.Med - 1991.- Vol.90(3), P310-314.
28. Suzuki J., Kawasaki Y, Nozawa R., et al. Oral disodium chro-moglycate and ketotifen for a patient with eosinophilic gastroenteritis, food allergy and protein-losing enteropathy // Asian Pac.J.Allergy Immunol.- 2003.- Vol.21(3).- P. 193-197.
29. De Maejer N., Kochuyt A. M., Van Moerkercke W., Hiele M. Mon-telukast as a treatment modality for eosinophilic gastroenteritis // Acta Gastroenterol.Belg.- 2011.- Vol.74(4).- P 570-575.
30. Prussin C., James S. P, Huber M. M. Pilot study of anti-IL-5 in eosinophilic gastroenteritis // J. Allergy Clin.Immunol.-2003.- Vol.111.- P 827.
31. Foroughi S, Foster B, Kim N, et al. Anti-IgE treatment of eo-sinophilassociated gastrointestinal disorders. J Allergy Clin Immunol - 2007.- Vol.120 - P 594-601.
32. Hommel K.A, Franciosi J.P Hente E.A, et al. Treatment adherence in pediatric eosinophilic gastrointestinal disorders. J Pediatr Psychol - 2012.- Vol.37 - P 533-542.
33. Kaur S, Rosen JM, Kriegermeier AA, et al. Utility of gastric and duodenal biopsies during follow-up endoscopy in children with eosinophilic esophagitis. J Pediatr Gastroenterol Nutr.-2017 - Vol.65 - P. 399-403
34. De Chambrun G. P., Gonzales F., Canva J.Y et al. Natural history of eosinophilic gastroenteritis // Clin.Gastroenterol.Hepa-tol - 2011.- Vol9(11).- P. 950-956.
Рецензия
Для цитирования:
Корниенко Е.А., Паролова Н.И., Волкова Н.Л., Шилова Е.В., Иванов Г.В., Лопатина Л.В. ЭОЗИНОФИЛЬНЫЙ ГАСТРИТ У ДЕТЕЙ. Клиническая эндоскопия. 2020;(1):18-26.

